nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
|
Miller, Eric J. |
|
|
6 |
5 |
p. 1559-1565 |
artikel |
2 |
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
|
Tey, Siok-Keen |
|
|
6 |
5 |
p. 1619-1622 |
artikel |
3 |
CAMK2G is identified as a novel therapeutic target for myelofibrosis
|
Miyauchi, Masashi |
|
|
6 |
5 |
p. 1585-1597 |
artikel |
4 |
Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
|
Grover, Punita |
|
|
6 |
5 |
p. 1608-1618 |
artikel |
5 |
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas
|
Koh, Min Jung |
|
|
6 |
5 |
p. 1420-1431 |
artikel |
6 |
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
|
Middeke, Jan M. |
|
|
6 |
5 |
p. 1394-1405 |
artikel |
7 |
Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
|
Portell, Craig A. |
|
|
6 |
5 |
p. 1490-1498 |
artikel |
8 |
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
|
Mizuno, Kana |
|
|
6 |
5 |
p. 1454-1463 |
artikel |
9 |
Editorial Board
|
|
|
|
6 |
5 |
p. i |
artikel |
10 |
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program
|
Johnson, Kirby D. |
|
|
6 |
5 |
p. 1464-1473 |
artikel |
11 |
Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis
|
Ito, Yusuke |
|
|
6 |
5 |
p. 1499-1511 |
artikel |
12 |
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
|
Avellino, Roberto |
|
|
6 |
5 |
p. 1406-1419 |
artikel |
13 |
Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
|
Chung, David J. |
|
|
6 |
5 |
p. 1547-1558 |
artikel |
14 |
M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands
|
Hason, Martina |
|
|
6 |
5 |
p. 1474-1488 |
artikel |
15 |
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
|
Fobare, Sydney |
|
|
6 |
5 |
p. 1371-1380 |
artikel |
16 |
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
|
Deeg, H. Joachim |
|
|
6 |
5 |
p. 1623-1627 |
artikel |
17 |
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
|
Wudhikarn, Kitsada |
|
|
6 |
5 |
p. 1432-1443 |
artikel |
18 |
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
|
Ali, Haris |
|
|
6 |
5 |
p. 1444-1453 |
artikel |
19 |
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
|
Haggenburg, Sabine |
|
|
6 |
5 |
p. 1537-1546 |
artikel |
20 |
SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
|
Malin, Jakob J. |
|
|
6 |
5 |
p. 1580-1584 |
artikel |
21 |
SARS-CoV-2–specific T-cell responses to recurrent COVID-19 pneumonitis in a patient with post-CART B-cell aplasia
|
Hodder, Angus |
|
|
6 |
5 |
p. 1577-1579 |
artikel |
22 |
Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice
|
Selma, Jada |
|
|
6 |
5 |
p. 1381-1393 |
artikel |
23 |
The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
|
Sacks, Naomi C. |
|
|
6 |
5 |
p. 1566-1576 |
artikel |
24 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma
|
Bonzheim, Irina |
|
|
6 |
5 |
p. 1598-1607 |
artikel |
25 |
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
|
Shouval, Roni |
|
|
6 |
5 |
p. 1525-1535 |
artikel |
26 |
Tiong IS, Dillon R, Ivey A, et al. Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood Adv. 2021;5(23):5107-5111.
|
|
|
|
6 |
5 |
p. 1489 |
artikel |
27 |
Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
|
Chiesa, Robert |
|
|
6 |
5 |
p. 1512-1524 |
artikel |
28 |
Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.
|
|
|
|
6 |
5 |
p. 1536 |
artikel |